Startup · $7.8m raised · Healthcare · AI
Programs: ANDHealth (ANDHealth+)
Every investor coverage indicates participated in a round Baymatob raised.
| Investor | Rounds | Invested |
|---|---|---|
| Alberts | Unnamed stage · Series A | - |
| Medical Research Future Fund | Grant | - |
| Australian Unity | Series A | - |
| Australian Unity's Future of Healthcare Fund | Series A | - |
| Global Bio Fund | Series A | - |
| ANDHealth | Accelerator | - |
Companies Baymatob acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming Baymatob. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Women's health founders say weak local investment is pushing them offshore; Baymatob, Ovum and BreastScreen leaders describe funding struggles at a Sydney summit, with all-female teams receiving just 2% of 2025 startup capital.
Eight Australian health startups received equity-free grants totaling 18.5 million dollars from the CUREator+ program, supported by government funding and delivered with partners Brandon BioCatalyst and ANDHealth.
Alberts' annual review records its venture arm closing its portfolio at 22 companies, topping up six holdings, co-launching a gender-equity drive, and navigating board changes after Sam Mostyn became Governor-General.
Also Startup Daily
Alberts Impact Ventures introduces its new investment associate in a Q&A covering his prior role at an investment platform, his path into impact investing, and portfolio companies in health and climate.
Roundup of seven Australian startups landing fresh capital and grants: Gaia EnviroTech's $4.3 million deal with RFM, four medtechs sharing $3.25 million via ANDHealth+, Q-CTRL's UK quantum prize, and CarbonHQ's $600,000 pre-seed.
Four Australian medtech companies have received a share of $3.25 million through the ANDHealth+ program, with the money aimed at clinical milestones and global expansion.
Also SmartCompany
Alberts Impact Ventures recaps 2022: six new portfolio companies, five follow-on investments, a led seed round in Abby Health, plus team events, a trade mission and investor recognition.
Also RenewEconomy·SmartCompany·Techboard·Startup Daily·Startup Daily·Startup Daily·SmartCompany·RenewEconomy
Alberts announces investment in Baymatob, whose Oli device predicts birth timing and detects hemorrhages, as the first deal in its Equality theme; CEO Tara Croft cites Australian Unity among capital partners in the raise.
Also Alberts Impact Ventures portfolio·Alberts Impact Ventures portfolio